Skip to main content
Backwork
Retired: GENETIC TESTING FOR FLT3, NPM1, CEBPA, IDH1 AND IDH2 VARIANTS IN ACUTE MYELOID LEUKEMIA (EFFECTIVE 09/01/2026) | Blue Cross Blue Shield of Michigan and Blue Care Network